● Recruiting

DESTINY-PANTUMOUR04

Condition: Adenocarcinoma (NOS) · Anal Cancer · Bladder Cancer · Sponsor: AstraZeneca

PhaseN/A

Planned participants100

Who can joinAll sexes, 18 Years to 130 Years

Healthy volunteersNo

About this study

This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior systemic treatment for metastatic or advanced disease and have no satisfactory alternative treatment options in a real-world setting in the US

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (18)

Research Site	Birmingham, Alabama, United States	Recruiting
Research Site	Bullhead City, Arizona, United States	Recruiting
Research Site	Casa Grande, Arizona, United States	Recruiting
Research Site	San Diego, California, United States	Recruiting
Research Site	Boulder, Colorado, United States	Recruiting
Research Site	Coral Springs, Florida, United States	Recruiting
Research Site	St. Petersburg, Florida, United States	Recruiting
Research Site	West Palm Beach, Florida, United States	Recruiting
Research Site	Decatur, Illinois, United States	Recruiting
Research Site	Topeka, Kansas, United States	Recruiting
Research Site	Farmington, New Mexico, United States	Recruiting
Research Site	Durham, North Carolina, United States	Recruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07124000